
GC19336
SR-3029
Also known as N-[(4,5-difluoro-1H-benzimidazol-2-yl)methyl]-9-(3-fluorophenyl)-2-morpholin-4-ylpurin-6-amine
SR-3029 is a potent and ATP competitive CK1δ and CK1ε inhibitor, with IC50s of 44 nM and 260 nM, respectively, and Kis of 97 nM for both kinases
ChemicalCAS1454585-06-8MW480.45FormulaC23H19F3N8O
- CAS number
- 1454585-06-8
- Molecular weight
- 480.45
- Formula
- C23H19F3N8O
- Solubility
- DMSO : ≥ 30 mg/mL (62·44 mM);Water : < 0·1 mg/mL (insoluble)
- InChIKey
- CEBMEQPREMCWOL-UHFFFAOYSA-N
- Catalogue number
- GC19336
- Brand
- GLPBIO
Computed properties PubChem CID 60196195 · XLogP 3.5 · TPSA 96.8 Ų · H-bond donors 2
- XLogP
- 3.5
- TPSA
- 96.8 Ų
- H-bond donors
- 2
- H-bond acceptors
- 10
- Rotatable bonds
- 5
- Heavy atoms
- 35
SMILES C1COCCN1C2=NC(=C3C(=N2)N(C=N3)C4=CC(=CC=C4)F)NCC5=NC6=C(N5)C=CC(=C6F)F
Computed descriptors from PubChem (CID 60196195), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il